A prospective cohort study on the effectiveness of 3500 IU versus 5000 IU bemiparin in the prophylaxis of postoperative thrombotic events in obese patients undergoing orthopedic surgery

Wiener Klinische Wochenschrift

Volumn 121, Issue 13-14, 2009, Pages 454-458

  Vavken, Patrick ^a,b   Lunzer, Andreas ^b   Grohs, Josef Georg ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Obesity; Orthopedic procedures; Orthopedics; Prophylaxis; Thrombosis

Indexed keywords

BEMIPARIN;

ADULT; AGE DISTRIBUTION; AGED; ANKLE ARTHRODESIS; ANTICOAGULANT THERAPY; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEMIPELVECTOMY; HUMAN; IMMOBILIZATION; INCIDENCE; JOINT PROSTHESIS; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; ORTHOPEDIC SURGERY; POSTOPERATIVE THROMBOSIS; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; THROMBOSIS PREVENTION; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

ADULT; AGED; ALGORITHMS; BODY WEIGHT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMOBILIZATION; LENGTH OF STAY; MALE; MIDDLE AGED; OBESITY; ORTHOPEDIC PROCEDURES; ORTHOPEDICS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TIME FACTORS;

EID: 68849121895     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-009-1175-x     Document Type: Article

References (17)

1. J Weitz 1997 Low-molecular-weight heparin N Engl J Med 337 10 668 698
2. MT Krauth I Pabinger 2007 [Venous thromboembolism] Wien Klin Wochenschr 119 5-6 Suppl 1 11 18 quiz 19
3. GD Paiement SJ Wessinger WH Harris 1987 Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery Clin Orthop Relat Res 223 188 193
4. I Pabinger S Eichinger E Minar H Niessner 2007 Austrian Guidelines for Prophylaxis of Venous Thromboembolism Wien Klin Wochenschr 119 23-24 739 746
5. PF Leyvraz F Bachmann J Hoek HR Buller M Postel M Samama 1991 Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin BMJ 303 6802 543 548
6. V Kakkar J Howes V Sharma Z Kadziola 2000 A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment Group Thromb Haemost 83 4 523 529
7. L Falkon D Saenz-Campos R Antonijoan S Martin M Barbanoj J Fontcuberta 1995 Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11) - a three way cross-over study in healthy volunteers Thromb Res 78 1 77 86
8. A Navarro-Quilis E Castellet E Rocha J Paz-Jiménez A Planès BSGiK Arthroplasty 2003 Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial J Thromb Haemost 1 3 425 432
9. J Honorato A Gómez-Outes A Navarro-Quilis J Martínez- González E Rocha A Planès 2004 Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery PharmacoEconomics 22 13 885 894
10. A Gómez-Outes E Rocha J Martínez-González V Kakkar 2006 Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis PharmacoEconomics 24 1 81 92
11. T Chapman K Goa 2003 Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis Drugs 63 21 2357 2377
12. P Vavken G Culen R Dorotka 2008 Management of confounding in controlled orthopaedic trials: a cross-sectional study Clin Orthop Relat Res 466 4 985 989
13. J Parvizi A Mui JJ Purtill PF Sharkey WJ Hozack RH Rothman 2007 Total joint arthroplasty: When do fatal or near-fatal complications occur? J Bone Joint Surg Am 89 1 27 32
14. D Bergqvist US Burmark PA Flordal J Frisell T Hallbook M Hedberg 1995 Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients Br J Surg 82 4 496 501
15. J Balibrea J Altimiras I Larruzea A Gómez-Outes J Martínez-González E Rocha 2007 Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice Int J Surg (London, England) 5 2 114 119
16. MR Lassen LC Borris HP Jensen KA Poulsen P Ejstrud BS Andersen 2000 Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty Clin Appl Thromb Hemost 6 1 53 57
17. J Adolf HM Fritsche S Haas FF Hennig T Horbach S Kastl 1999 Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group Int Angiol 18 2 122 126